关注
Jay Schneider
Jay Schneider
在 jefferson.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Lead neurotoxicity in children: basic mechanisms and clinical correlates
TI Lidsky, JS Schneider
Brain 126 (1), 5-19, 2003
14692003
Manganese: recent advances in understanding its transport and neurotoxicity
M Aschner, TR Guilarte, JS Schneider, W Zheng
Toxicology and applied pharmacology 221 (2), 131-147, 2007
7092007
The neurobiological basis of cognitive impairment in Parkinson's disease
GM Halliday, JB Leverenz, JS Schneider, CH Adler
Movement disorders 29 (5), 634-650, 2014
4172014
Sensory and cognitive functions of the basal ganglia
LL Brown, JS Schneider, TI Lidsky
Current opinion in neurobiology 7 (2), 157-163, 1997
3921997
Chronic exposure to low doses of MPTP. I. Cognitive deficits in motor asymptomatic monkeys
JS Schneider, CJ Kovelowski II
Brain research 519 (1-2), 122-128, 1990
2841990
A consideration of sensory factors involved in motor functions of the basal ganglia
TI Lidsky, C Manetto, JS Schneider
Brain Research Reviews 9 (2), 133-146, 1985
2631985
Binding of [99mTc] TRODAT-1 to dopamine transporters in patients with Parkinson's disease and in healthy volunteers
PD Mozley, JS Schneider, PD Acton, K Plössl, MB Stern, A Siderowf, ...
Journal of Nuclear Medicine 41 (4), 584-589, 2000
2372000
Parkinson's disease: sensory and motor problems in arms and hands
JS Schneider, SG Diamond, CH Markham
Neurology 37 (6), 951-951, 1987
2131987
Deficits in orofacial sensorimotor function in Parkinson's disease
JS Schneider, SG Diamond, CH Markham
Annals of neurology 19 (3), 275-282, 1986
2131986
Nigrostriatal dopamine system dysfunction and subtle motor deficits in manganese-exposed non-human primates
TR Guilarte, MK Chen, JL McGlothan, T Verina, DF Wong, Y Zhou, ...
Experimental neurology 202 (2), 381-390, 2006
2082006
Recovery from experimental parkinsonism in primates with GM1 ganglioside treatment
JS Schneider, A Pope, K Simpson, J Taggart, MG Smith, L DiStefano
Science 256 (5058), 843-846, 1992
2061992
Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP
JS Schneider, A Yuwiler, CH Markham
Brain research 411 (1), 144-150, 1987
1871987
Dopaminergic neurons derived from human induced pluripotent stem cells survive and integrate into 6-OHDA-lesioned rats
J Cai, M Yang, E Poremsky, S Kidd, JS Schneider, L Iacovitti
Stem cells and development 19 (7), 1017-1023, 2010
1852010
Impairment of nigrostriatal dopamine neurotransmission by manganese is mediated by pre‐synaptic mechanism (s): implications to manganese‐induced parkinsonism
TR Guilarte, NC Burton, JL McGlothan, T Verina, Y Zhou, M Alexander, ...
Journal of neurochemistry 107 (5), 1236-1247, 2008
1772008
Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial
K Kieburtz, BC Tilley, JJ Elm, D Babcock, R Hauser, GW Ross, ...
Jama 313 (6), 584-593, 2015
1732015
A randomized, controlled, delayed start trial of GM1 ganglioside in treated Parkinson's disease patients
JS Schneider, SM Gollomp, S Sendek, A Colcher, F Cambi, W Du
Journal of the neurological sciences 324 (1-2), 140-148, 2013
1642013
GM1 ganglioside in Parkinson's disease: Results of a five year open study
JS Schneider, S Sendek, C Daskalakis, F Cambi
Journal of the neurological sciences 292 (1-2), 45-51, 2010
1622010
Production of a Parkinson-like syndrome in the cat with N-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP): behavior, histology, and biochemistry
JS Schneider, A Yuwiler, CH Markham
Experimental neurology 91 (2), 293-307, 1986
1441986
Adverse effects of childhood lead poisoning: the clinical neuropsychological perspective
TI Lidsky, JS Schneider
Environmental research 100 (2), 284-293, 2006
1422006
Evidence for Cortical Dysfunction and Widespread Manganese Accumulation in the Nonhuman Primate Brain following Chronic Manganese Exposure: A 1H-MRS …
TR Guilarte, JL McGlothan, M Degaonkar, MK Chen, PB Barker, ...
Toxicological sciences 94 (2), 351-358, 2006
1392006
系统目前无法执行此操作,请稍后再试。
文章 1–20